Search research articles
Contact Us
Filters
Showing results (51-60 of 113) with videos related to
Page
of 12
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
January 15, 1989
Lymphokine-activated tumor inhibition in mice. Ability of a nonapeptide of the human IL-1 beta to recruit anti-tumor reactivity in recipient mice
G Forni, T Musso, C Jemma, et al.
La Ricerca in Clinica E in Laboratorio
|
October 1, 1985
Interferon-gamma plays a crucial role in T lymphocyte reaction against alloantigens
S Landolfo, F Cofano, M Giovarelli, et al.
Nature
|
November 10, 1983
Radiofrequency destruction of the tuberoinfundibular region of hypothalamus permanently abrogates NK cell activity in mice
G Forni, M Bindoni, A Santoni, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement
|
January 1, 1989
Lymphokine-activated tumor inhibition: combinatory activity of a synthetic nonapeptide from interleukin-1, interleukin-2, interleukin-4, and interferon-gamma injected around tumor-draining lymph nodes
G Forni, M Giovarelli, M C Bosco, et al.
Natural Immunity and Cell Growth Regulation
|
January 1, 1986
Modulation of natural killer activity in mice by prolonged administration of various doses of dietary retinoids
A Santoni, S Cerruti Sola, M Giovarelli, et al.
Journal of the National Cancer Institute
|
March 1, 1986
Effect of prolonged administration of low doses of dietary retinoids on cell-mediated immunity and the growth of transplantable tumors in mice
G Forni, S Cerruti Sola, M Giovarelli, et al.
European Cytokine Network
|
June 5, 1998
Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection
E Di Carlo, A Coletti, A Modesti, et al.
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1993
Strategies for cytokine utilisation in tumor therapy
F Di Pierro, F Cavallo, F Pericle, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 15, 1991
Blockade of physiologically secreted IFN-gamma inhibits human T lymphocyte and natural killer cell activation
F Novelli, M Giovarelli, R Reber-Liske, et al.
Leukemia Research
|
January 1, 1988
Release of interleukin-2-like material by B-chronic lymphocytic leukemia cells. An autocrine or paracrine model of production and utilization?
M Giovarelli, R Foa, G Benetton, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 113) with videos related to
Sort By:
Page
of 12
Journal of Immunology (Baltimore, Md. : 1950)
|
January 15, 1989
Lymphokine-activated tumor inhibition in mice. Ability of a nonapeptide of the human IL-1 beta to recruit anti-tumor reactivity in recipient mice
G Forni, T Musso, C Jemma, et al.
La Ricerca in Clinica E in Laboratorio
|
October 1, 1985
Interferon-gamma plays a crucial role in T lymphocyte reaction against alloantigens
S Landolfo, F Cofano, M Giovarelli, et al.
Nature
|
November 10, 1983
Radiofrequency destruction of the tuberoinfundibular region of hypothalamus permanently abrogates NK cell activity in mice
G Forni, M Bindoni, A Santoni, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement
|
January 1, 1989
Lymphokine-activated tumor inhibition: combinatory activity of a synthetic nonapeptide from interleukin-1, interleukin-2, interleukin-4, and interferon-gamma injected around tumor-draining lymph nodes
G Forni, M Giovarelli, M C Bosco, et al.
Natural Immunity and Cell Growth Regulation
|
January 1, 1986
Modulation of natural killer activity in mice by prolonged administration of various doses of dietary retinoids
A Santoni, S Cerruti Sola, M Giovarelli, et al.
Journal of the National Cancer Institute
|
March 1, 1986
Effect of prolonged administration of low doses of dietary retinoids on cell-mediated immunity and the growth of transplantable tumors in mice
G Forni, S Cerruti Sola, M Giovarelli, et al.
European Cytokine Network
|
June 5, 1998
Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection
E Di Carlo, A Coletti, A Modesti, et al.
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1993
Strategies for cytokine utilisation in tumor therapy
F Di Pierro, F Cavallo, F Pericle, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 15, 1991
Blockade of physiologically secreted IFN-gamma inhibits human T lymphocyte and natural killer cell activation
F Novelli, M Giovarelli, R Reber-Liske, et al.
Leukemia Research
|
January 1, 1988
Release of interleukin-2-like material by B-chronic lymphocytic leukemia cells. An autocrine or paracrine model of production and utilization?
M Giovarelli, R Foa, G Benetton, et al.
Page
of 12